Umbilical Cord Stem Cells Show Promise as Covid-19 Therapy Acute Respiratory Distress Syndrome (ARDS), Autologous Mesenchymal Stem Cells (MSCs), Clinical Trials, COVID-19 Therapies, Cytokine Storm, R&D, Stem Cell Translational Medicine, Stem Cells, Umbilical Cord Stem Cells, University of Miami Mesenchymal stem cells derived from umbilical cord tissue could help treat ARDS in Covid-19 patients, according to results of a Phase I/IIa clinical trial published by University of Miami researchers. Read more January 16, 2021/by Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2021/01/Umbilical-Cord-Stem-Cells-Show-Promise-as-COVID-19-Therapy-BioSpace-1-15-21.jpeg 350 625 Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Andrew Humphreys2021-01-16 02:23:492021-01-16 02:24:36Umbilical Cord Stem Cells Show Promise as Covid-19 Therapy